BDBM50211322 CHEMBL391530::N-((1s,4s)-4-(4-(2-isopropoxyphenyl)piperazin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide

SMILES: COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCN(CC1)c1ccccc1OC(C)C

InChI Key: InChIKey=YJXYZPLPRPNAPZ-SZPZYZBQSA-N

Data: 12 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 12 hits for monomerid = 50211322   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Alpha-1D adrenergic receptor (Homo sapiens (Human))	BDBM50211322 (CHEMBL391530 | N-((1s,4s)-4-(4-(2-isopropoxyphenyl...) Show SMILES COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCN(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.45,6.98,;7.93,6.98,;7.17,5.66,;5.62,5.66,;4.85,4.32,;5.62,3,;7.17,3,;7.93,4.32,;9.48,4.32,;10.24,3,;4.85,1.66,;3.52,2.44,;6.19,.9,;4.08,.34,;2.54,.34,;1.78,-.99,;.24,-.99,;-.52,.34,;.24,1.67,;1.77,1.67,;-2.05,.34,;-2.82,-.99,;-4.36,-.99,;-5.12,.35,;-4.36,1.67,;-2.82,1.67,;-6.67,.35,;-7.43,-1.02,;-8.98,-1.02,;-9.75,.33,;-8.98,1.67,;-7.43,1.67,;-6.67,3,;-7.44,4.33,;-6.67,5.67,;-8.98,4.33,)| Show InChI InChI=1S/C27H39N3O5S/c1-20(2)35-25-8-6-5-7-24(25)30-17-15-29(16-18-30)22-11-9-21(10-12-22)28-36(31,32)23-13-14-26(33-3)27(19-23)34-4/h5-8,13-14,19-22,28H,9-12,15-18H2,1-4H3/t21-,22+	Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	0.680	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development L.L.C. Curated by ChEMBL					Assay Description Binding affinity to human cloned adrenergic alpha1d receptor				Bioorg Med Chem Lett 17: 6123-8 (2007) Article DOI: 10.1016/j.bmcl.2007.09.051 BindingDB Entry DOI: 10.7270/Q2C82925
					More data for this Ligand-Target Pair
Alpha-1D adrenergic receptor (Homo sapiens (Human))	BDBM50211322 (CHEMBL391530 | N-((1s,4s)-4-(4-(2-isopropoxyphenyl...) Show SMILES COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCN(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.45,6.98,;7.93,6.98,;7.17,5.66,;5.62,5.66,;4.85,4.32,;5.62,3,;7.17,3,;7.93,4.32,;9.48,4.32,;10.24,3,;4.85,1.66,;3.52,2.44,;6.19,.9,;4.08,.34,;2.54,.34,;1.78,-.99,;.24,-.99,;-.52,.34,;.24,1.67,;1.77,1.67,;-2.05,.34,;-2.82,-.99,;-4.36,-.99,;-5.12,.35,;-4.36,1.67,;-2.82,1.67,;-6.67,.35,;-7.43,-1.02,;-8.98,-1.02,;-9.75,.33,;-8.98,1.67,;-7.43,1.67,;-6.67,3,;-7.44,4.33,;-6.67,5.67,;-8.98,4.33,)| Show InChI InChI=1S/C27H39N3O5S/c1-20(2)35-25-8-6-5-7-24(25)30-17-15-29(16-18-30)22-11-9-21(10-12-22)28-36(31,32)23-13-14-26(33-3)27(19-23)34-4/h5-8,13-14,19-22,28H,9-12,15-18H2,1-4H3/t21-,22+	Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development L.L.C. Curated by ChEMBL					Assay Description Binding affinity to human cloned adrenergic alpha1D receptor				Bioorg Med Chem Lett 17: 3292-7 (2007) Article DOI: 10.1016/j.bmcl.2007.04.008 BindingDB Entry DOI: 10.7270/Q2PG1RDH
					More data for this Ligand-Target Pair
Alpha-1A adrenergic receptor (Homo sapiens (Human))	BDBM50211322 (CHEMBL391530 | N-((1s,4s)-4-(4-(2-isopropoxyphenyl...) Show SMILES COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCN(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.45,6.98,;7.93,6.98,;7.17,5.66,;5.62,5.66,;4.85,4.32,;5.62,3,;7.17,3,;7.93,4.32,;9.48,4.32,;10.24,3,;4.85,1.66,;3.52,2.44,;6.19,.9,;4.08,.34,;2.54,.34,;1.78,-.99,;.24,-.99,;-.52,.34,;.24,1.67,;1.77,1.67,;-2.05,.34,;-2.82,-.99,;-4.36,-.99,;-5.12,.35,;-4.36,1.67,;-2.82,1.67,;-6.67,.35,;-7.43,-1.02,;-8.98,-1.02,;-9.75,.33,;-8.98,1.67,;-7.43,1.67,;-6.67,3,;-7.44,4.33,;-6.67,5.67,;-8.98,4.33,)| Show InChI InChI=1S/C27H39N3O5S/c1-20(2)35-25-8-6-5-7-24(25)30-17-15-29(16-18-30)22-11-9-21(10-12-22)28-36(31,32)23-13-14-26(33-3)27(19-23)34-4/h5-8,13-14,19-22,28H,9-12,15-18H2,1-4H3/t21-,22+	Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	1.60	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development L.L.C. Curated by ChEMBL					Assay Description Binding affinity to human cloned adrenergic alpha1A receptor				Bioorg Med Chem Lett 17: 3292-7 (2007) Article DOI: 10.1016/j.bmcl.2007.04.008 BindingDB Entry DOI: 10.7270/Q2PG1RDH
					More data for this Ligand-Target Pair
Alpha-1A adrenergic receptor (Homo sapiens (Human))	BDBM50211322 (CHEMBL391530 | N-((1s,4s)-4-(4-(2-isopropoxyphenyl...) Show SMILES COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCN(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.45,6.98,;7.93,6.98,;7.17,5.66,;5.62,5.66,;4.85,4.32,;5.62,3,;7.17,3,;7.93,4.32,;9.48,4.32,;10.24,3,;4.85,1.66,;3.52,2.44,;6.19,.9,;4.08,.34,;2.54,.34,;1.78,-.99,;.24,-.99,;-.52,.34,;.24,1.67,;1.77,1.67,;-2.05,.34,;-2.82,-.99,;-4.36,-.99,;-5.12,.35,;-4.36,1.67,;-2.82,1.67,;-6.67,.35,;-7.43,-1.02,;-8.98,-1.02,;-9.75,.33,;-8.98,1.67,;-7.43,1.67,;-6.67,3,;-7.44,4.33,;-6.67,5.67,;-8.98,4.33,)| Show InChI InChI=1S/C27H39N3O5S/c1-20(2)35-25-8-6-5-7-24(25)30-17-15-29(16-18-30)22-11-9-21(10-12-22)28-36(31,32)23-13-14-26(33-3)27(19-23)34-4/h5-8,13-14,19-22,28H,9-12,15-18H2,1-4H3/t21-,22+	Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development L.L.C. Curated by ChEMBL					Assay Description Binding affinity to human cloned adrenergic alpha1a receptor				Bioorg Med Chem Lett 17: 6123-8 (2007) Article DOI: 10.1016/j.bmcl.2007.09.051 BindingDB Entry DOI: 10.7270/Q2C82925
					More data for this Ligand-Target Pair
Alpha-1D adrenergic receptor (Homo sapiens (Human))	BDBM50211322 (CHEMBL391530 | N-((1s,4s)-4-(4-(2-isopropoxyphenyl...) Show SMILES COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCN(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.45,6.98,;7.93,6.98,;7.17,5.66,;5.62,5.66,;4.85,4.32,;5.62,3,;7.17,3,;7.93,4.32,;9.48,4.32,;10.24,3,;4.85,1.66,;3.52,2.44,;6.19,.9,;4.08,.34,;2.54,.34,;1.78,-.99,;.24,-.99,;-.52,.34,;.24,1.67,;1.77,1.67,;-2.05,.34,;-2.82,-.99,;-4.36,-.99,;-5.12,.35,;-4.36,1.67,;-2.82,1.67,;-6.67,.35,;-7.43,-1.02,;-8.98,-1.02,;-9.75,.33,;-8.98,1.67,;-7.43,1.67,;-6.67,3,;-7.44,4.33,;-6.67,5.67,;-8.98,4.33,)| Show InChI InChI=1S/C27H39N3O5S/c1-20(2)35-25-8-6-5-7-24(25)30-17-15-29(16-18-30)22-11-9-21(10-12-22)28-36(31,32)23-13-14-26(33-3)27(19-23)34-4/h5-8,13-14,19-22,28H,9-12,15-18H2,1-4H3/t21-,22+	Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	19	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development L.L.C. Curated by ChEMBL					Assay Description Binding affinity to human cloned adrenergic alpha1D receptor				Bioorg Med Chem Lett 17: 3292-7 (2007) Article DOI: 10.1016/j.bmcl.2007.04.008 BindingDB Entry DOI: 10.7270/Q2PG1RDH
					More data for this Ligand-Target Pair
Alpha-1A adrenergic receptor (Homo sapiens (Human))	BDBM50211322 (CHEMBL391530 | N-((1s,4s)-4-(4-(2-isopropoxyphenyl...) Show SMILES COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCN(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.45,6.98,;7.93,6.98,;7.17,5.66,;5.62,5.66,;4.85,4.32,;5.62,3,;7.17,3,;7.93,4.32,;9.48,4.32,;10.24,3,;4.85,1.66,;3.52,2.44,;6.19,.9,;4.08,.34,;2.54,.34,;1.78,-.99,;.24,-.99,;-.52,.34,;.24,1.67,;1.77,1.67,;-2.05,.34,;-2.82,-.99,;-4.36,-.99,;-5.12,.35,;-4.36,1.67,;-2.82,1.67,;-6.67,.35,;-7.43,-1.02,;-8.98,-1.02,;-9.75,.33,;-8.98,1.67,;-7.43,1.67,;-6.67,3,;-7.44,4.33,;-6.67,5.67,;-8.98,4.33,)| Show InChI InChI=1S/C27H39N3O5S/c1-20(2)35-25-8-6-5-7-24(25)30-17-15-29(16-18-30)22-11-9-21(10-12-22)28-36(31,32)23-13-14-26(33-3)27(19-23)34-4/h5-8,13-14,19-22,28H,9-12,15-18H2,1-4H3/t21-,22+	Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	61	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development L.L.C. Curated by ChEMBL					Assay Description Binding affinity to human cloned adrenergic alpha1A receptor				Bioorg Med Chem Lett 17: 3292-7 (2007) Article DOI: 10.1016/j.bmcl.2007.04.008 BindingDB Entry DOI: 10.7270/Q2PG1RDH
					More data for this Ligand-Target Pair
D(2) dopamine receptor (Homo sapiens (Human))	BDBM50211322 (CHEMBL391530 | N-((1s,4s)-4-(4-(2-isopropoxyphenyl...) Show SMILES COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCN(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.45,6.98,;7.93,6.98,;7.17,5.66,;5.62,5.66,;4.85,4.32,;5.62,3,;7.17,3,;7.93,4.32,;9.48,4.32,;10.24,3,;4.85,1.66,;3.52,2.44,;6.19,.9,;4.08,.34,;2.54,.34,;1.78,-.99,;.24,-.99,;-.52,.34,;.24,1.67,;1.77,1.67,;-2.05,.34,;-2.82,-.99,;-4.36,-.99,;-5.12,.35,;-4.36,1.67,;-2.82,1.67,;-6.67,.35,;-7.43,-1.02,;-8.98,-1.02,;-9.75,.33,;-8.98,1.67,;-7.43,1.67,;-6.67,3,;-7.44,4.33,;-6.67,5.67,;-8.98,4.33,)| Show InChI InChI=1S/C27H39N3O5S/c1-20(2)35-25-8-6-5-7-24(25)30-17-15-29(16-18-30)22-11-9-21(10-12-22)28-36(31,32)23-13-14-26(33-3)27(19-23)34-4/h5-8,13-14,19-22,28H,9-12,15-18H2,1-4H3/t21-,22+	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	94	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development L.L.C. Curated by ChEMBL					Assay Description Binding affinity to human dopamine D2 receptor				Bioorg Med Chem Lett 17: 3292-7 (2007) Article DOI: 10.1016/j.bmcl.2007.04.008 BindingDB Entry DOI: 10.7270/Q2PG1RDH
					More data for this Ligand-Target Pair
Adrenergic alpha1B (Homo sapiens (Human))	BDBM50211322 (CHEMBL391530 | N-((1s,4s)-4-(4-(2-isopropoxyphenyl...) Show SMILES COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCN(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.45,6.98,;7.93,6.98,;7.17,5.66,;5.62,5.66,;4.85,4.32,;5.62,3,;7.17,3,;7.93,4.32,;9.48,4.32,;10.24,3,;4.85,1.66,;3.52,2.44,;6.19,.9,;4.08,.34,;2.54,.34,;1.78,-.99,;.24,-.99,;-.52,.34,;.24,1.67,;1.77,1.67,;-2.05,.34,;-2.82,-.99,;-4.36,-.99,;-5.12,.35,;-4.36,1.67,;-2.82,1.67,;-6.67,.35,;-7.43,-1.02,;-8.98,-1.02,;-9.75,.33,;-8.98,1.67,;-7.43,1.67,;-6.67,3,;-7.44,4.33,;-6.67,5.67,;-8.98,4.33,)| Show InChI InChI=1S/C27H39N3O5S/c1-20(2)35-25-8-6-5-7-24(25)30-17-15-29(16-18-30)22-11-9-21(10-12-22)28-36(31,32)23-13-14-26(33-3)27(19-23)34-4/h5-8,13-14,19-22,28H,9-12,15-18H2,1-4H3/t21-,22+	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	106	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development L.L.C. Curated by ChEMBL					Assay Description Binding affinity to human cloned adrenergic alpha1b receptor				Bioorg Med Chem Lett 17: 6123-8 (2007) Article DOI: 10.1016/j.bmcl.2007.09.051 BindingDB Entry DOI: 10.7270/Q2C82925
					More data for this Ligand-Target Pair
Adrenergic alpha1B (Homo sapiens (Human))	BDBM50211322 (CHEMBL391530 | N-((1s,4s)-4-(4-(2-isopropoxyphenyl...) Show SMILES COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCN(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.45,6.98,;7.93,6.98,;7.17,5.66,;5.62,5.66,;4.85,4.32,;5.62,3,;7.17,3,;7.93,4.32,;9.48,4.32,;10.24,3,;4.85,1.66,;3.52,2.44,;6.19,.9,;4.08,.34,;2.54,.34,;1.78,-.99,;.24,-.99,;-.52,.34,;.24,1.67,;1.77,1.67,;-2.05,.34,;-2.82,-.99,;-4.36,-.99,;-5.12,.35,;-4.36,1.67,;-2.82,1.67,;-6.67,.35,;-7.43,-1.02,;-8.98,-1.02,;-9.75,.33,;-8.98,1.67,;-7.43,1.67,;-6.67,3,;-7.44,4.33,;-6.67,5.67,;-8.98,4.33,)| Show InChI InChI=1S/C27H39N3O5S/c1-20(2)35-25-8-6-5-7-24(25)30-17-15-29(16-18-30)22-11-9-21(10-12-22)28-36(31,32)23-13-14-26(33-3)27(19-23)34-4/h5-8,13-14,19-22,28H,9-12,15-18H2,1-4H3/t21-,22+	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	109	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development L.L.C. Curated by ChEMBL					Assay Description Binding affinity to human cloned adrenergic alpha1B receptor				Bioorg Med Chem Lett 17: 3292-7 (2007) Article DOI: 10.1016/j.bmcl.2007.04.008 BindingDB Entry DOI: 10.7270/Q2PG1RDH
					More data for this Ligand-Target Pair
Adrenergic alpha1B (Homo sapiens (Human))	BDBM50211322 (CHEMBL391530 | N-((1s,4s)-4-(4-(2-isopropoxyphenyl...) Show SMILES COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCN(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.45,6.98,;7.93,6.98,;7.17,5.66,;5.62,5.66,;4.85,4.32,;5.62,3,;7.17,3,;7.93,4.32,;9.48,4.32,;10.24,3,;4.85,1.66,;3.52,2.44,;6.19,.9,;4.08,.34,;2.54,.34,;1.78,-.99,;.24,-.99,;-.52,.34,;.24,1.67,;1.77,1.67,;-2.05,.34,;-2.82,-.99,;-4.36,-.99,;-5.12,.35,;-4.36,1.67,;-2.82,1.67,;-6.67,.35,;-7.43,-1.02,;-8.98,-1.02,;-9.75,.33,;-8.98,1.67,;-7.43,1.67,;-6.67,3,;-7.44,4.33,;-6.67,5.67,;-8.98,4.33,)| Show InChI InChI=1S/C27H39N3O5S/c1-20(2)35-25-8-6-5-7-24(25)30-17-15-29(16-18-30)22-11-9-21(10-12-22)28-36(31,32)23-13-14-26(33-3)27(19-23)34-4/h5-8,13-14,19-22,28H,9-12,15-18H2,1-4H3/t21-,22+	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	112	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development L.L.C. Curated by ChEMBL					Assay Description Binding affinity to human cloned adrenergic alpha1B receptor				Bioorg Med Chem Lett 17: 3292-7 (2007) Article DOI: 10.1016/j.bmcl.2007.04.008 BindingDB Entry DOI: 10.7270/Q2PG1RDH
					More data for this Ligand-Target Pair
D(2) dopamine receptor (Homo sapiens (Human))	BDBM50211322 (CHEMBL391530 | N-((1s,4s)-4-(4-(2-isopropoxyphenyl...) Show SMILES COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCN(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.45,6.98,;7.93,6.98,;7.17,5.66,;5.62,5.66,;4.85,4.32,;5.62,3,;7.17,3,;7.93,4.32,;9.48,4.32,;10.24,3,;4.85,1.66,;3.52,2.44,;6.19,.9,;4.08,.34,;2.54,.34,;1.78,-.99,;.24,-.99,;-.52,.34,;.24,1.67,;1.77,1.67,;-2.05,.34,;-2.82,-.99,;-4.36,-.99,;-5.12,.35,;-4.36,1.67,;-2.82,1.67,;-6.67,.35,;-7.43,-1.02,;-8.98,-1.02,;-9.75,.33,;-8.98,1.67,;-7.43,1.67,;-6.67,3,;-7.44,4.33,;-6.67,5.67,;-8.98,4.33,)| Show InChI InChI=1S/C27H39N3O5S/c1-20(2)35-25-8-6-5-7-24(25)30-17-15-29(16-18-30)22-11-9-21(10-12-22)28-36(31,32)23-13-14-26(33-3)27(19-23)34-4/h5-8,13-14,19-22,28H,9-12,15-18H2,1-4H3/t21-,22+	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	136	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development L.L.C. Curated by ChEMBL					Assay Description Binding affinity to human cloned dopamine D2 receptor				Bioorg Med Chem Lett 17: 6123-8 (2007) Article DOI: 10.1016/j.bmcl.2007.09.051 BindingDB Entry DOI: 10.7270/Q2C82925
					More data for this Ligand-Target Pair
D(2) dopamine receptor (Homo sapiens (Human))	BDBM50211322 (CHEMBL391530 | N-((1s,4s)-4-(4-(2-isopropoxyphenyl...) Show SMILES COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCN(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.45,6.98,;7.93,6.98,;7.17,5.66,;5.62,5.66,;4.85,4.32,;5.62,3,;7.17,3,;7.93,4.32,;9.48,4.32,;10.24,3,;4.85,1.66,;3.52,2.44,;6.19,.9,;4.08,.34,;2.54,.34,;1.78,-.99,;.24,-.99,;-.52,.34,;.24,1.67,;1.77,1.67,;-2.05,.34,;-2.82,-.99,;-4.36,-.99,;-5.12,.35,;-4.36,1.67,;-2.82,1.67,;-6.67,.35,;-7.43,-1.02,;-8.98,-1.02,;-9.75,.33,;-8.98,1.67,;-7.43,1.67,;-6.67,3,;-7.44,4.33,;-6.67,5.67,;-8.98,4.33,)| Show InChI InChI=1S/C27H39N3O5S/c1-20(2)35-25-8-6-5-7-24(25)30-17-15-29(16-18-30)22-11-9-21(10-12-22)28-36(31,32)23-13-14-26(33-3)27(19-23)34-4/h5-8,13-14,19-22,28H,9-12,15-18H2,1-4H3/t21-,22+	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	810	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development L.L.C. Curated by ChEMBL					Assay Description Binding affinity to human dopamine D2 receptor				Bioorg Med Chem Lett 17: 3292-7 (2007) Article DOI: 10.1016/j.bmcl.2007.04.008 BindingDB Entry DOI: 10.7270/Q2PG1RDH
					More data for this Ligand-Target Pair